• Explore /
  • Poster
  • / Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer.

Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer.

Abstract Poster

Authors

null

Wassim Abida

Memorial Sloan Kettering Cancer Center, New York, NY

Wassim Abida , Matthew I. Milowsky , Irina Ostrovnaya , Scott R. Gerst , Jonathan E. Rosenberg , Ashley Marie Regazzi , Asia S. McCoy , Mariel Elena Boyd , Dean F. Bajorin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT01182168

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 322)

DOI

10.1200/jco.2015.33.7_suppl.322

Abstract #

322

Poster Bd #

F9

Abstract Disclosures

Similar Posters

First Author: Ryan Leibrandt

First Author: John Ebben

First Author: Samuel Aaron Funt

First Author: Jennifer Rachel Eads